draflazine has been researched along with dilazep in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heitman, LH; IJzerman, AP; Vlachodimou, A | 1 |
| Van Belle, H; Ver Donck, K; Wynants, J | 1 |
| Van Belle, H; Ver Donck, KL; Verheyen, WJ | 1 |
| Iimura, O; Itoya, M; Miura, T; Sakamoto, J; Urabe, K | 1 |
| Baldwin, SA; Cass, CE; Hyde, RJ; McConkey, GA; McRobert, L; Parker, MD; Yao, SY; Young, JD | 1 |
| Archer, RG; Hammond, JR; McConnell, K; Stolk, M | 1 |
| Archer, RG; Hammond, JR; Pitelka, V | 1 |
| Bone, DB; Hammond, JR | 1 |
| Baldwin, SA; Cass, CE; Damaraju, V; Paproski, RJ; Tackaberry, T; Visser, F; Young, JD; Zhang, J | 1 |
| Heitman, LH; IJzerman, AP; Konstantinopoulou, K; Vlachodimou, A | 1 |
10 other study(ies) available for draflazine and dilazep
| Article | Year |
|---|---|
Label-free detection of transporter activity via GPCR signalling in living cells: A case for SLC29A1, the equilibrative nucleoside transporter 1.
Topics: Cell Line, Tumor; Equilibrative Nucleoside Transporter 1; Humans; Ligands; Membrane Transport Proteins; Osteosarcoma; Receptors, G-Protein-Coupled; Receptors, Purinergic P1; Signal Transduction | 2019 |
Comparison of the existing nucleoside transport inhibitors: in vitro and in vivo data.
Topics: Animals; Biological Transport; Dilazep; Dipyridamole; Epinephrine; Erythrocytes; Humans; In Vitro Techniques; Nucleosides; Phosphates; Piperazines; Rabbits; Thioinosine | 1991 |
Nucleoside transport inhibition and fMLP-stimulated whole blood luminescence.
Topics: Adenosine; Biological Transport; Dilazep; Dipyridamole; Humans; Luminescent Measurements; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Piperazines; Respiratory Burst | 1991 |
Nucleoside transport inhibitors enhance the infarct size-limiting effect of ischemic preconditioning.
Topics: Animals; Blood Pressure; Dilazep; Disease Models, Animal; Epoprostenol; Heart Rate; Injections, Intravenous; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Nucleosides; Phosphoric Diester Hydrolases; Piperazines; Platelet Aggregation Inhibitors; Rabbits | 1994 |
Identification of a nucleoside/nucleobase transporter from Plasmodium falciparum, a novel target for anti-malarial chemotherapy.
Topics: Adenine; Amino Acid Sequence; Animals; Antimalarials; Biological Transport; Blotting, Southern; Carrier Proteins; Cations; Cell Membrane; Cloning, Molecular; Dilazep; Dipyridamole; Dose-Response Relationship, Drug; Hydrogen-Ion Concentration; Kinetics; Molecular Sequence Data; Nucleobase, Nucleoside, Nucleotide, and Nucleic Acid Transport Proteins; Nucleosides; Phylogeny; Piperazines; Plasmodium falciparum; Platelet Aggregation Inhibitors; Protein Structure, Secondary; Protozoan Proteins; Sequence Homology, Amino Acid; Substrate Specificity; Thioinosine; Time Factors; Uridine; Vasodilator Agents; Xenopus | 2000 |
Pharmacological analysis and molecular cloning of the canine equilibrative nucleoside transporter 1.
Topics: Amino Acid Sequence; Animals; Binding, Competitive; Carrier Proteins; Cell Line; Cloning, Molecular; Dilazep; Dipyridamole; DNA, Complementary; Dogs; Dose-Response Relationship, Drug; Equilibrative Nucleoside Transporter 1; Formycins; Kinetics; Molecular Sequence Data; Piperazines; Protein Binding; Protein Conformation; Radioligand Assay; Sequence Alignment; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Structure-Activity Relationship; Thioinosine; Tritium | 2004 |
Nucleoside transporter subtype expression and function in rat skeletal muscle microvascular endothelial cells.
Topics: Animals; Capillaries; Cell Separation; Cells, Cultured; Dilazep; Dipyridamole; DNA Primers; Endothelial Cells; Formycins; Muscle, Skeletal; Nucleoside Transport Proteins; Piperazines; Radioligand Assay; Rats; Reverse Transcriptase Polymerase Chain Reaction; Thioinosine; Vasodilator Agents | 2004 |
Nucleoside and nucleobase transporters of primary human cardiac microvascular endothelial cells: characterization of a novel nucleobase transporter.
Topics: 2-Chloroadenosine; Animals; Cell Culture Techniques; Cell Line; Cells, Cultured; Child, Preschool; Coronary Vessels; Dilazep; Dipyridamole; Dogs; Endothelial Cells; Equilibrative Nucleoside Transporter 1; Equilibrative-Nucleoside Transporter 2; Female; Humans; Hypoxanthine; Kinetics; Microcirculation; Nucleobase Transport Proteins; Piperazines; Protein Binding; Purines; Rats; Swine; Thioinosine; Transfection; Tritium | 2007 |
Mutation of Trp29 of human equilibrative nucleoside transporter 1 alters affinity for coronary vasodilator drugs and nucleoside selectivity.
Topics: Adenosine; Biological Transport; Dilazep; Dipyridamole; Enzyme Activation; Equilibrative Nucleoside Transporter 1; Humans; Kinetics; Models, Biological; Mutation; Nucleosides; Piperazines; Protein Binding; Thioinosine; Tryptophan; Vasodilator Agents | 2008 |
Affinity, binding kinetics and functional characterization of draflazine analogues for human equilibrative nucleoside transporter 1 (SLC29A1).
Topics: Cardiotonic Agents; Cell Line, Tumor; Dilazep; Dipyridamole; Equilibrative Nucleoside Transporter 1; Humans; Molecular Structure; Piperazines; Protein Binding; Radioligand Assay; Structure-Activity Relationship | 2020 |